| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:517838383:1380 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:517838383:1380?format=raw |
LEADER: 01380cam a2200373 a 4500
001 3960646
005 20221027010502.0
008 911002t19911991nyu b 001 0 eng c
010 $a 91007864
020 $a0881677671
035 $a(OCoLC)23144415
035 $a(OCoLC)ocm23144415
035 $a(CStRLIN)NYCM91-B5801
035 $9AFS7392HS
035 $a(NNC)3960646
035 $a3960646
040 $aDNLM/DLC$cDLC$dNNC-M
050 00 $aR853.C55$bS652 1991
060 0 $aQV 771 S756gb
082 00 $a615/.028/7$220
100 1 $aSpilker, Bert.$0http://id.loc.gov/authorities/names/n84025421
245 10 $aGuide to clinical trials /$cBert Spilker.
260 $aNew York :$bRaven Press,$c[1991], ©1991.
300 $axxiv, 1156 pages :$billustrations ;$c29 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
500 $aIncludes indexes.
504 $aIncludes bibliographical references (p. 1079-1103) and indexes.
650 0 $aClinical trials.$0http://id.loc.gov/authorities/subjects/sh85027069
650 0 $aDrugs$xTesting.$0http://id.loc.gov/authorities/subjects/sh85039755
650 2 $aClinical Trials as Topic.$0https://id.nlm.nih.gov/mesh/D002986
650 2 $aDrug Evaluation.$0https://id.nlm.nih.gov/mesh/D004341
650 2 $aResearch Design.$0https://id.nlm.nih.gov/mesh/D012107
852 00 $boff,hsl$hR853.C55$iS652 1991 Q